Systemic and Local Cytokine Production in Quiescent Ulcerative Colitis and Its Relationship to Future Relapse: A Prospective Pilot Study

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Inflammatory Bowel Diseases

• Publication date

  2005-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/01.MIB.0000161917.97136.e2PMID 15905707
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mucosal cytokine production during remission after resection for Crohn's disease and its relationship to future relapse

  2004cited by this paper
• How effective are the usual treatments for ulcerative colitis?

  2004cited by this paper
• Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis.

  2001cited by this paper
• Gut Mucosal Secretion of Interleukin 1β and Interleukin-8 Predicts Relapse in Clinically Inactive Crohn's Disease

  2001cited by this paper
• Frequently relapsing Crohn's disease is characterized by persistent elevation in interleukin-6 and soluble interleukin-2 receptor serum levels during remission

  2000cited by this paper
• Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission

  2000cited by this paper
• Tumour necrosis factor alpha and interleukin 1beta in relapse of Crohn's disease.

  1999cited by this paper
• Tumour necrosis factor α and interleukin 1β in relapse of Crohn's disease

  1999cited by this paper
• Inflammatory bowel disease: etiology and pathogenesis.

  1998cited by this paper
• Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.

  1997cited by this paper
• A high serum concentration of interleukin‐6 is predictive of relapse in quiescent Crohn's disease

  1997cited by this paper
• Role of interleukin 8 on leucocyte-endothelial cell adhesion in intestinal inflammation.

  1996cited by this paper
• Interleukin 8: cells of origin in inflammatory bowel disease.

  1996cited by this paper
• An Oral Preparation of Mesalamine as Long-Term Maintenance Therapy for Ulcerative Colitis

  1996cited by this paper
• Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease.

  1996cited by this paper
• Modulation of cytokine release from human monocytes by drugs used in the therapy of inflammatory bowel diseases.

  1995cited by this paper
• Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis. Pentasa UC Maintenance Study Group.

  1995cited by this paper
• The effect of treatment on lymphokine‐secreting cells in the intestinal mucosa of children with Crohn's disease

  1995cited by this paper
• Production and Cellular Source of Interleukin‐8 in Ulcerative Colitis

  1995influential reference
• Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis

  1995cited by this paper
• Soluble interleukin-2 receptor in Crohn's disease. Assessment of disease activity and prediction of relapse.

  1995cited by this paper
• Course of ulcerative colitis: analysis of changes in disease activity over years.

  1994cited by this paper
• Interrelations between interleukin-6, interleukin-1 beta, plasma C-reactive protein values, and in vitro C-reactive protein generation in patients with inflammatory bowel disease.

  1994cited by this paper
• Olsalazine in maintenance of clinical remission in patients with ulcerative colitis

  1993cited by this paper
• Cytokine Induction in Experimental and Ulcerative Colitis

  1992cited by this paper
• Effect of aminophenols (5-ASA and 4-ASA) on colonic interleukin-1 generation.

  1992cited by this paper
• Colonic mucosal interleukin-6 in inflammatory bowel disease.

  1991cited by this paper
• Pathogenetic and clinical relevance of cytokines in inflammatory bowel disease

  1991cited by this paper
• Reply

  1990cited by this paper
• Role of interleukin 1 in inflammatory bowel disease--enhanced production during active disease.

  1990cited by this paper
• Why do patients with ulcerative colitis relapse?

  1990cited by this paper
• Thyroid hormone regulation of neurons staining for a pro-TRH-derived cryptic peptide sequence in the rat hypothalamic paraventricular nucleus.

  1989cited by this paper
• Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease.

  1989cited by this paper
• Monokine-induced neutrophil chemotactic factor gene expression in human fibroblasts.

  1989cited by this paper
• Secretion of novel and homologous neutrophil-activating peptides by LPS-stimulated human endothelial cells.

  1989cited by this paper
• Ulcerative colitis in remission: it is possible to predict the risk of relapse?

  1989cited by this paper
• Monokine-induced gene expression of a human endothelial cell-derived neutrophil chemotactic factor.

  1988cited by this paper
• 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis.

  1987cited by this paper
• A laboratory index for predicting relapse in asymptomatic patients with Crohn's disease.

  1986cited by this paper
• Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. A comparison with colonoscopy, histology, and fecal indium 111-granulocyte excretion.

  1986influential reference
• C-Reactive Protein as a Predictor of Relapse in Asymptomatic Patients with Crohn's Disease

  1983cited by this paper
• The course and prognosis of ulcerative colitis

  1963cited by this paper

• Interleukin Signatures as Prognostic Biomarkers in Ulcerative Colitis: From Immune Pathways to Clinical Prediction.

  2026cites this paper
• Mucosal interleukin‐8 expression as a predictor of subsequent relapse in ulcerative colitis patients with Mayo endoscopic subscore 0

  2022cites this paper
• Cytokine Profile at Diagnosis Affecting Trough Concentration of Infliximab in Pediatric Crohn’s Disease

  2022cites this paper
• Biomarker signatures in pathophysiology and therapeutic interventions in inflammatory bowel diseases

  2022cites this paper
• The role of alcohol dehydrogenase 1C in regulating inflammatory responses in ulcerative colitis.

  2021cites this paper
• Targeting the ileo-colonic region in inflammatory bowel disease

  2021cites this paper
• Increased mucosal IL-12 expression is associated with relapse of ulcerative colitis

  2021cites this paper
• Mucosal IL23A expression predicts the response to Ustekinumab in inflammatory bowel disease

  2021cites this paper
• Infliximab formulation strategy for a stable ileo-colonic targeted oral dosage form intended for the topical treatment of inflammatory bowel disease

  2021cites this paper
• Microbiome‐skin‐brain axis: A novel paradigm for cutaneous wounds

  2020cites this paper
• Review: Local Tumor Necrosis Factor-α Inhibition in Inflammatory Bowel Disease

  2020cites this paper
• Mucosal Profiles of Immune Molecules Related to T Helper and Regulatory T Cells Predict Future Relapse in Patients With Quiescent Ulcerative Colitis.

  2019cites this paper
• A Combined Set of Four Serum Inflammatory Biomarkers Reliably Predicts Endoscopic Disease Activity in Inflammatory Bowel Disease

  2019cites this paper
• Higher serum vitamin D levels are associated with protective serum cytokine profiles in patients with ulcerative colitis

  2018cites this paper
• Role of adiponectin in patients with inflammatory bowel disease unclassified

  2018cites this paper
• How to predict clinical relapse in inflammatory bowel disease patients.

  2016cites this paper
• Mucus mediated protection against acute colitis in adiponectin deficient mice

  2015cites this paper
• Gene Expression Analysis of Peripheral Cells for Subclassification of Pediatric Inflammatory Bowel Disease in Remission

  2013cites this paper
• CD14+CD33+ myeloid cell‐CCL11‐eosinophil signature in ulcerative colitis

  2013cites this paper
• Cytokine mucosal expression in ulcerative colitis, the relationship between cytokine release and disease activity.

  2013cites this paper
• Serum IL-17A in Newly Diagnosed Treatment-Naive Patients with Ulcerative Colitis Reflects Clinical Disease Severity and Predicts the Course of Disease

  2013cites this paper
• Prevention of Chronic Experimental Colitis Induced by Dextran Sulphate Sodium (DSS) in Mice Treated with FR91

  2012influential citation
• Role of serum cytokine profile in ulcerative colitis assessment

  2012cites this paper
• Evaluation of inflammatory activity in Crohn's disease and ulcerative colitis.

  2012cites this paper
• Predictors of aggressive inflammatory bowel disease.

  2011cites this paper
• Candidate mucosal and surrogate biomarkers of inflammatory bowel disease in the era of new technology

  2011cites this paper
• Novel Techniques in Endoscopy Are Useful in Evaluating Patients with Ulcerative Colitis

  2011cites this paper
• Circulating Cytokines Reflect Mucosal Inflammatory Status in Patients with Crohn’s Disease

  2010cites this paper
• Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis?

  2010cites this paper
• Butyrate enemas do not affect human colonic MUC2 and TFF3 expression

  2010cites this paper
• Mucosal biomarkers in inflammatory bowel disease: key pathogenic players or disease predictors?

  2010cites this paper
• Can systemic cytokines predict relapse of inflammatory bowel disease?

  2010cites this paper
• TLR4 monoclonal antibody blockade suppresses dextran‐sulfate‐sodium‐induced colitis in mice

  2010cites this paper
• Down-regulation of Protein and mRNA Expression of IL-8 and ICAM-1 in Colon Tissue of Ulcerative Colitis Patients by Partition-Herb Moxibustion

  2009cites this paper
• Localized inflammation in peripheral tissue signals the CNS for sickness response in the absence of interleukin-1 and COX-2 in the blood and brain

  2009cites this paper
• An unexpected cause of chronic diarrhoea

  2008cites this paper
• Can Calprotectin Predict Relapse Risk in Inflammatory Bowel Disease?

  2008cites this paper
• Therapeutic effect of epigallocatechin-3-gallate in a mouse model of colitis.

  2008cites this paper
• Chemokines orchestrate leukocyte trafficking in inflammatory bowel disease.

  2008cites this paper
• Mucosal inflammation in the terminal ileum of ulcerative colitis patients: endoscopic findings and cytokine profiles.

  2008cites this paper
• Localized inflammation in peripheral tissue signals the CNS for sickness response in the absence of interleukin-1 and cyclooxygenase-2 in the blood and brain.

  2008cites this paper
• Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis

  2008cites this paper
• Immune-To-Brain Signaling: How Important are the Blood–Brain Barrier-independent Pathways?

  2008cites this paper
• Impacts of long‐term enteral nutrition on clinical and endoscopic disease activities and mucosal cytokines during remission in patients with Crohn's disease: A prospective study

  2007cites this paper
• Elevated urinary cytokine levels in patients undergoing ileal neobladder replacement compared with sigmoid neobladder replacement

  2007cites this paper
• Impact of selective leukocytapheresis on mucosal inflammation and ulcerative colitis: Cytokine profiles and endoscopic findings

  2006cites this paper
• Pit patterns in rectal mucosa assessed by magnifying colonoscope are predictive of relapse in patients with quiescent ulcerative colitis

  2006cites this paper
• Review article: biological activity markers in inflammatory bowel disease

  2006cites this paper
• ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets.

  2006cites this paper
• Migration of zebrafish primordial germ cells: a role for myosin contraction and cytoplasmic flow.

  2006cites this paper
• The Impact of the Fecal Stream and Stasis on Immunologic Reactions in Ileal Pouch After Restorative Proctocolectomy for Ulcerative Colitis: A Prospective, Pilot Study

  2005cites this paper